by Steven Grossman | Aug 18, 2025 | Uncategorized
Dear FDA Matters subscribers Q&A Monday is a subscriber-first feature of FDA Matters. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon receipt.Subscribers are encouraged to submit questions about any...
by Steven Grossman | Aug 11, 2025 | Uncategorized
Dear FDA Matters subscribers–—“Q&A Friday” is now “Q&A Monday,” a subscriber-first feature of FDA Matters. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon receipt.Subscribers are encouraged to submit...
by Steven Grossman | Aug 4, 2025 | Uncategorized
Dear FDA Matters subscribers–—“Q&A Friday” is now “Q&A Monday” so that I can thoughtfully answer questions based on the past week’s news. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon...
by Steven Grossman | Jul 25, 2025 | Uncategorized
Dear FDA Matters subscribers–—Each “Q&A Friday” will go to subscribers first, then posted on the website a week later. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon receipt.Subscribers are encouraged...
by Steven Grossman | Jul 19, 2025 | Uncategorized
Dear FDA Matters subscribers–—Second edition of Q&A Friday, a new feature for subscribers. Each “Q&A Friday” will go to subscribers first, then posted on the website a week later. It is on the record, so subscribers (including reporters) can use and circulate...
by Steven Grossman | Jul 4, 2025 | Uncategorized
Dear FDA Matters subscribers–Introducing Q&A Friday, a new feature for subscribers.Each Friday’s Q&A will go to subscribers first, then it will be posted on the website about a week later. Like all FDA Matters analysis (including everything on the website) it...
